BioScale was founded in 2002 by CEO Mark Lundstrom and three interdisciplinary MIT professors. Since then the Company has assembled development, engineering, manufacturing and an industry-seasoned commercial team to globally launch the AMMP assay technology and ViBE platform into the pharmaceutical, biotech, life science, and bioprocess markets. It is also pursuing partnering for diagnostic and specialty applications. The Company’s new 30,000 sq. ft. global headquarters and manufacturing site are located in Lexington, Massachusetts. BioScale develops, manufactures and promotes a sophisticated protein measurement technology to accelerate drug discovery, development and production of biological and pharmaceutical products.